Literature DB >> 25480678

Bare platinum coils vs. HydroCoil in the treatment of unruptured intracranial aneurysms-A single center randomized controlled study.

Wojciech Poncyljusz1, Artur Zarzycki2, Łukasz Zwarzany3, Thomas H Burke4.   

Abstract

PURPOSE: The HydroCoil Embolic System (HES) was developed to improve aneurysm filling to provide superior occlusion efficacy, reduce retreatment rates and enhance long-term durability. We performed a randomized clinical trial to compare the effectiveness of bare platinum coils (BPC) vs. HES for unruptured intracranial aneurysms.
METHODS: Ninety-six patients underwent endovascular coiling of unruptured intracranial aneurysms. The aneurysms were randomized equally to receive BPC or HES. Immediate angiographic results, number of coils used and complications were evaluated and all cases had 12-month follow-up angiography.
RESULTS: Immediate angiographic results demonstrated that 84.0% of aneurysms treated with HES were completely occluded compared to 76.1% of aneurysms treated with BPC (p=0.3310). The mean number of coils utilized to fill the aneurysm was significantly lower in the HES arm (5.04 vs. 6.93). Additional adjunctive techniques were performed in 51.1% of all cases. There were seven patients (7.3%) with postoperative complications during the study period. The coil type used during the treatment did not demonstrate any significant differences on the overall recurrence rate (HES - 18.0%, BPC - 17.4%, p=0.9712). There was a statistically significant difference in the aneurysm size and the neck width between completely occluded aneurysms and aneurysms with residual flow in both immediate angiographic and mid-term follow-up.
CONCLUSIONS: Overall, aneurysm size and neck width are the main risk factors associated with aneurysm recurrence. HES compared to BPC required less total number of coils to provide a denser aneurysm filling. However, there were equivocal results with both devices, at the mid-term angiographic follow-up.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Embolization; HydroCoil; Intracranial aneurysm; Platinum coil

Mesh:

Substances:

Year:  2014        PMID: 25480678     DOI: 10.1016/j.ejrad.2014.11.002

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  5 in total

1.  European Stroke Organisation (ESO) guidelines on management of unruptured intracranial aneurysms.

Authors:  Nima Etminan; Diana Aguiar de Sousa; Cindy Tiseo; Romain Bourcier; Hubert Desal; Anttii Lindgren; Timo Koivisto; David Netuka; Simone Peschillo; Sabrina Lémeret; Avtar Lal; Mervyn DI Vergouwen; Gabriel Je Rinkel
Journal:  Eur Stroke J       Date:  2022-06-03

2.  Long-Term Rupture Risk in Patients with Unruptured Intracranial Aneurysms Treated with Endovascular Therapy: A Systematic Review and Meta-Analysis.

Authors:  A Rizvi; S M Seyedsaadat; M Alzuabi; M H Murad; R Kadirvel; W Brinjikji; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-28       Impact factor: 3.825

3.  Evaluation of Endovascular Embolization of Cerebral Aneurysms by Hydrogel Coils.

Authors:  Daniel Knap; Wojciech Gruszka; Dominik Sieroń; Katarzyna Gruszczyńska; Michał Zawadzki; Miłosz Zbroszczyk; Jan Baron
Journal:  Pol J Radiol       Date:  2017-04-10

Review 4.  Efficacy and Safety of Different Bioactive Coils in Intracranial Aneurysm Interventional Treatment, a Systematic Review and Bayesian Network Meta-Analysis.

Authors:  Jie Zhang; Guannan Jiang; Zhaoming Song; Wei Cheng; Wenxue Wu; Zhouqing Chen; Zhong Wang; Wanchun You; Gang Chen
Journal:  Brain Sci       Date:  2022-08-10

5.  Hydrogel coils versus bare platinum coils for the endovascular treatment of intracranial aneurysms: a meta-analysis of randomized controlled trials.

Authors:  Tao Xue; Zhouqing Chen; Weiwei Lin; Jiayi Xu; Xuming Shen; Zhong Wang
Journal:  BMC Neurol       Date:  2018-10-05       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.